Organic Letters
Letter
251. For azicemicins A and B, see: (c) Tsuchida, T.; Iinuma, H.;
Kinoshita, N.; Ikeda, T.; Sawa, R.; Takahashi, Y.; Naganawa, H.; Sawa,
T.; Hamada, M.; Takeuchi, T. J. Antibiot. 1993, 46, 1772. (d) Tsuchida,
T.; Iinuma, H.; Kinoshita, N.; Ikeda, T.; Sawa, T.; Hamada, M.;
Takeuchi, T. J. Antibiot. 1995, 48, 217. (e) Tsuchida, T.; Sawa, R.;
Takahashi, Y.; Iinuma, H.; Sawa, T.; Naganawa, H.; Takeuchi, T. J.
Antibiot. 1995, 48, 1148. For miraziridine A, see: (f) Nakao, Y.; Fujita,
M.; Warabi, K.; Matsunaga, S.; Fusetani, N. J. Am. Chem. Soc. 2000,
122, 10462. (g) Konno, H.; Kubo, K.; Makabe, H.; Toshiro, E.;
Hinoda, N.; Nosaka, K.; Akaji, K. Tetrahedron 2007, 63, 9502. For
reviews of other biological active compounds, see: (h) Ismail, F. M. D.;
Levitsky, D. O.; Dembitsky, V. M. Eur. J. Med. Chem. 2009, 44, 3373.
(i) Singh, G. S. Mini-Rev. Med. Chem. 2016, 16, 892.
AUTHOR INFORMATION
■
Corresponding Author
ORCID
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
This work was supported by a Grant-in-Aid for Scientific
Research on Innovative Areas “Advanced Molecular Trans-
formations by Organocatalysts” from MEXT (26105727) and
the Tatematsu Foundation.
(10) (a) Nakamura, S.; Hayama, D. Angew. Chem., Int. Ed. 2017, 56,
8785. For pioneering works on enantioselective nucleophilic addition
reactions with 2H-azirines, see: (b) Risberg, E.; Somfai, P. Tetrahedron:
Asymmetry 2002, 13, 1957. (c) An, D.; Guan, X.; Guan, R.; Jin, L.;
Zhang, G.; Zhang, S. Chem. Commun. 2016, 52, 11211. For kinetic
resolution of 2H-azirines, see: (d) Hu, H.; Liu, Y.; Lin, L.; Zhang, Y.;
Liu, X.; Feng, X. Angew. Chem., Int. Ed. 2016, 55, 10098. For
REFERENCES
■
(1) For selected reviews, see: (a) Shibasaki, M.; Kanai, M. Org.
Biomol. Chem. 2007, 5, 2027. (b) Riant, O.; Hannedouche, J. Org.
Biomol. Chem. 2007, 5, 873. (c) Cozzi, P. G.; Hilgraf, R.;
Zimmermann, N. Eur. J. Org. Chem. 2007, 2007, 5969. (d) Shibasaki,
M.; Kanai, M. For selected recent examples, see. Chem. Rev. 2008, 108,
2853. (e) Chen, Q. G.; Xie, L. H.; Li, Z. J.; Tang, Y.; Zhao, P.; Lin, L.
L.; Feng, X. M.; Liu, X. H. Chem. Commun. 2018, 54, 678.
(2) For β-lactam antibiotics, see: (a) Sammes, P. G. Chem. Rev. 1976,
76, 113. (b) The Organic Chemistry of β-Lactams; Georg, G. I., Ed.;
VCH: New York, 1993. For fusaperazine A, see: (c) Usami, Y.; Aoki,
S.; Hara, T.; Numata, A. J. Antibiot. 2002, 55, 655. For the fungal
metabolite (+)-11,11′-dideoxyverticillin A, see: (d) Kim, J.;
Ashenhurst, J. A.; Movassaghi, M. Science 2009, 324, 238.
(e) Bertamino, A.; Soprano, M.; Musella, S.; Rusciano, M. R.; Sala,
M.; Vernieri, E.; Di Sarno, V.; Limatola, A.; Carotenuto, A.; Cosconati,
S.; Grieco, P.; Novellino, E.; Illario, M.; Campiglia, P.; Gomez-
Monterrey, I. J. Med. Chem. 2013, 56, 5407.
(3) (a) Nakamura, S.; Takahashi, S.; Nakane, D.; Masuda, S. Org.
Lett. 2015, 17, 106. For recent studies on enantioselective reactions
with ketimines from our group, see: (b) Nakamura, S.; Hayashi, M.;
Hiramatsu, Y.; Shibata, N.; Funahashi, Y.; Toru, T. J. Am. Chem. Soc.
2009, 131, 18240. (c) Hara, N.; Nakamura, S.; Sano, M.; Tamura, R.;
Funahashi, Y.; Shibata, N. Chem. - Eur. J. 2012, 18, 9276. (d) Hayashi,
M.; Sano, M.; Funahashi, Y.; Nakamura, S. Angew. Chem., Int. Ed.
2013, 52, 5557. (e) Hayashi, M.; Iwanaga, M.; Shiomi, N.; Nakane, D.;
Masuda, H.; Nakamura, S. Angew. Chem., Int. Ed. 2014, 53, 8411.
(f) Nakamura, S.; Sano, M.; Toda, A.; Nakane, D.; Masuda, H. Chem. -
Eur. J. 2015, 21, 3929. (g) Nakamura, S.; Yamaji, R.; Hayashi, M.
Chem. - Eur. J. 2015, 21, 9615. (h) Nakamura, S.; Takahashi, S. Org.
Lett. 2015, 17, 2590. (i) Nakamura, S.; Matsuda, N.; Ohara, M. Chem. -
Eur. J. 2016, 22, 9478. (j) Nakamura, S.; Yamaji, R.; Iwanaga, M. Chem.
Commun. 2016, 52, 7462.
́
diastereoselective reactions of 2H-azirines with thiols, see: (e) Alvares,
Y. S. P.; Alves, M. J.; Azoia, N. G.; Bickley, J. F.; Gilchrist, T. L. J.
Chem. Soc. Perkin Trans. 1 2002, 1, 1911. (f) Palacios, F.; Ochoa de
Retana, A. M.; Alonso, J. M. J. Org. Chem. 2005, 70, 8895.
(11) The reaction without catalyst gave the product in 80% yield. We
also examined the reaction using a bis(imidazoline)zinc(II) catalyst,
which was a good catalyst for the enantioselective reaction of azirines
with phosphites, but the enantioselectivity of the product was low (5%
ee, 88% yield). See ref 10a.
(12) For N-heteroarenesulfonylated cinchona alkaloid amide
catalysts, see: (a) Hara, N.; Nakamura, S.; Funahashi, Y.; Shibata, N.
Adv. Synth. Catal. 2011, 353, 2976. (b) Hara, N.; Nakamura, S.; Sano,
M.; Tamura, R.; Funahashi, Y.; Shibata, N. Chem. - Eur. J. 2012, 18,
9276. (c) Nakamura, S.; Toda, A.; Sano, M.; Hatanaka, T.; Funahashi,
Y. Adv. Synth. Catal. 2016, 358, 1029. Also see refs 3f and 3h.
(13) We also examined the reactions of azirine 2a with p-
chlorophenol and benzyl alcohol, but the yield or enantioselectivity
was low.
(14) For activation of cyclopropane cleavage by Lawesson’s reagent
as a Lewis acid, see: (a) Kaschel, J.; Schmidt, C. D.; Mumby, M.;
Kratzert, D.; Stalke, D.; Werz, D. B. Chem. Commun. 2013, 49, 4403.
(b) Hadj-Abo, F.; Bienz, S.; Hesse, M. Tetrahedron 1994, 50, 8665.
For a review of Lawesson’s reagent, see: (c) Jesberger, M.; Davis, T. P.;
Barner, L. Synthesis 2003, 2003, 1929. For the synthesis of oxazolines
from aziridines using Lewis acids, see: (d) Heine, H. W.; Proctor, Z. J.
Org. Chem. 1958, 23, 1554. (e) Ferraris, D.; Drury, W. J.; Cox, C.;
Lectka, T. J. Org. Chem. 1998, 63, 4568. (f) Cardillo, G.; Gentilucci, L.;
Tolomelli, A. Tetrahedron 1999, 55, 15151. (g) Cockrell, J.;
Wilhelmsen, C.; Rubin, H.; Martin, A.; Morgan, J. B. Angew. Chem.,
Int. Ed. 2012, 51, 9842.
(15) For α- or β-aminosulfones, see: (a) Micetich, R. G.; Maiti, S. N.;
Spevak, P.; Hall, T. W.; Yamabe, S.; Ishida, N.; Tanaka, M.; Yamazaki,
T.; Nakai, A.; Ogawa, K. J. Med. Chem. 1987, 30, 1469. (b) Vintonyak,
(4) Beceno, C.; Chauhan, P.; Rembiak, A.; Wang, A.; Enders, D. Adv.
̃
Synth. Catal. 2015, 357, 672.
́ ̌
(5) Suc, J.; Dokli, I.; Gredicak, M. Chem. Commun. 2016, 52, 2071.
(6) Unhale, R. A.; Molleti, N.; Rana, N. K.; Dhanasekaran, S.;
Bhandary, S.; Singh, V. K. Tetrahedron Lett. 2017, 58, 145.
V. V.; Warburg, K.; Kruse, H.; Grimme, S.; Hubel, K.; Rauh, D.;
̈
Waldmann, H. Angew. Chem., Int. Ed. 2010, 49, 5902. (c) Miller, B. E.;
Mistry, S.; Smart, K.; Connolly, P.; Carpenter, D. C.; Cooray, H.;
Bloomer, J. C.; Tal-Singer, R.; Lazaar, A. L. BMC Pharmacol. Toxicol.
(7) There have been several reports on the enantioselective reaction
of aldimines with thiols. See: (a) Ingle, G. K.; Mormino, M. G.;
Wojtas, L.; Antilla, J. C. Org. Lett. 2011, 13, 4822. (b) Fang, X.; Li, Q.-
H.; Tao, H.-Y.; Wang, C.-J. Adv. Synth. Catal. 2013, 355, 327.
(c) Wang, H.-Y.; Zhang, J.-X.; Cao, D.-D.; Zhao, G. ACS Catal. 2013,
3, 2218. (d) Qian, H.; Sun, J. Asian J. Org. Chem. 2014, 3, 387.
(e) Feng, B.-X.; Wang, B.; Li, X. Org. Biomol. Chem. 2016, 14, 9206.
(8) (a) Tanner, D. Angew. Chem., Int. Ed. Engl. 1994, 33, 599.
(b) McCoull, W.; Davis, F. A. Synthesis 2000, 2000, 1347. (c) Hu, X. E.
Tetrahedron 2004, 60, 2701. (d) Pineschi, M. Eur. J. Org. Chem. 2006,
2006, 4979. (e) Schneider, C. Angew. Chem., Int. Ed. 2009, 48, 2082.
(9) For mitomycin C, see: (a) Hata, T.; Hoshi, T.; Kanamori, K.;
Matsumae, A.; Sano, Y.; Shima, T.; Sugawara, R. J. Antibiot. 1956, 9,
141. (b) Mao, Y.; Varoglu, M.; Sherman, D. H. Chem. Biol. 1999, 6,
2015, 16, 18. For α-sulfonyl esters, see: (d) Leon
P.; Rodríguez, C. M.; Ravelo, J. L.; Martín, V. S.; Padron
Med. Chem. Lett. 2008, 18, 5171.
́
, L. G.; Machín, R.
́
, J. M. Bioorg.
D
Org. Lett. XXXX, XXX, XXX−XXX